Key result
Early CRP-guided diagnosis and intervention for anastomotic leakage mitigates adverse oncological outcomes in rectal cancer.
Why the study?
Does early biochemical diagnosis of anastomotic leakage improve oncological outcomes in patients with rectal cancer?
Population
Patients with rectal cancer
Authors
Loading...
May support CRP surveillance for early AL in rectal cancer; leaves open oncological benefit confirmation in randomized trials.
Does early biochemical diagnosis of anastomotic leakage improve oncological outcomes in patients with rectal cancer?
Early biochemical diagnosis of anastomotic leakage using C-reactive protein mitigates its negative impact on oncological outcomes in rectal cancer patients.
Denost et al. (2021) studied this question. Early biochemical diagnosis and intervention of anastomotic leakage using elevated C-reactive protein mitigates its negative impact on oncological outcomes in patients with rectal cancer.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: